Supernus Pharmaceuticals Quote - 0LB2

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

55.00

Bid

0.00

Ask

0.00

Volume

720

0.00 Day's Range 0.00

55.00 52 Week Range 55.00

Market Cap

3.005B

Previous Close

55.00

Open

Last Trade

100

38.69

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

302

Shares Outstanding

54,633,000

Dividend Yield

PE Ratio

1,591.29

Earnings Per Share (EPS)

0.02

Revenue

609.04M

Net Profit

1.32M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.supernus.com

Headquarters

Wilmington, Delaware, USA

Founded

Supernus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0LB2. The last closing price for Supernus Pharmaceuticals was US$55. Over the last year, Supernus Pharmaceuticals shares have traded in a share price range of US$ 55.00 to US$ 55.00.

Supernus Pharmaceuticals currently has 54,633,000 shares outstanding. The market capitalization of Supernus Pharmaceuticals is US$3 billion. Supernus Pharmaceuticals has a price to earnings ratio (PE ratio) of 1591.29.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	55	55	55	442	55	DE
4	55	55	55	193	55	DE
12	55	55	55	302	55	DE
26	55	55	55	190	55	DE
52	55	55	55	132	55	DE
156	55	55	55	73	55	DE
260	55	55	55	65	55	DE

0LB2 - Frequently Asked Questions (FAQ)

What is the current Supernus Pharmaceuticals share price?

The current share price of Supernus Pharmaceuticals is US$ 55.00

How many Supernus Pharmaceuticals shares are in issue?

Supernus Pharmaceuticals has 54,633,000 shares in issue

What is the market cap of Supernus Pharmaceuticals?

The market capitalisation of Supernus Pharmaceuticals is USD 3B

What is the 1 year trading range for Supernus Pharmaceuticals share price?

Supernus Pharmaceuticals has traded in the range of US$ 55.00 to US$ 55.00 during the past year

What is the PE ratio of Supernus Pharmaceuticals?

The price to earnings ratio of Supernus Pharmaceuticals is 1.59k

What is the cash to sales ratio of Supernus Pharmaceuticals?

The cash to sales ratio of Supernus Pharmaceuticals is 3.44

What is the reporting currency for Supernus Pharmaceuticals?

Supernus Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Supernus Pharmaceuticals?

The latest annual turnover of Supernus Pharmaceuticals is USD 609.04M

What is the latest annual profit for Supernus Pharmaceuticals?

The latest annual profit of Supernus Pharmaceuticals is USD 1.32M

What is the registered address of Supernus Pharmaceuticals?

The registered address for Supernus Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Supernus Pharmaceuticals website address?

The website address for Supernus Pharmaceuticals is www.supernus.com

Which industry sector does Supernus Pharmaceuticals operate in?

Supernus Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AIQAiq Limited	4.00p (33.33%)	37.88k
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
ALKAlkemy Capital Investments Plc	175.00p (27.27%)	176.27k
KNBKanabo Group Plc	1.00p (25.00%)	461.04k
TCFTheracryf Plc	1.125p (25.00%)	6.72M
MET1Metals One Plc	0.275p (-35.29%)	16.2M
PPSProton Motor Power Systems Plc	0.175p (-22.22%)	848.7k
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M
CGNRConroy Gold & Natural Resources Plc	2.15p (-18.87%)	739.53k
ONCOncimmune Holdings Plc	10.40p (-16.47%)	1.19M
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
NTVONativo Resources Plc	0.0018p (-5.26%)	1.41B
MSMNMosman Oil And Gas Limited	0.041p (10.81%)	1.22B
TRPTower Resources Plc	0.0295p (0.00%)	691.76M
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M